References
Du Y, Zhu J, Chu BF, et al. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1a-mediated VEGF signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(15):6570-6578.
Dandare A, Rabia G, Khan MJ. In silico analysis of non-coding RNAs and putative target genes implicated in metabolic syndrome. Comput Biol Med. 2021;130:104229.
Fiebelkow J, Guendel A, Guendel B, et al. The tyrosine phosphatase SHP2 increases robustness and information transfer within IL-6-induced JAK/STAT signalling. Cell Commun Signal. 2021;19(1):94.
Xin P, Xu X, Deng C, et al. The role of JAK/STAT signaling pathway and its inhibitors in diseases. Int Immunopharm. 2020;80:106210.
Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5(9):1315-1316.